These compounds may interact with:
Platelet-activating factor receptor
Potentially involved in: carcinoma; pneumonia; liver cirrhosis, experimental; polycystic ovary syndrome; active ulcerative colitis; amyotrophic lateral sclerosis; cystic fibrosis; fascioscapulohumeral muscular dystrophy; gastric carcinoma; hepatocellular carcinoma; interstitial cystitis; juvenile dermatomyositis; medulloblastoma, large-cell; mucosa-associated lymphoid tissue lymphoma; osteosarcoma; ovarian cancer; pancreatic cancer; pancreatic carcinoma; psoriasis; tuberculosis
Disease data sourced from Pharos.